How much does Keytruda cost?
Keytruda (pembrolizumab) is typically priced in the U.S. as a prescription, hospital-administered cancer drug, with the “official” (list) price varying by dose and schedule. Actual out-of-pocket costs depend heavily on insurance coverage, patient assistance, and whether the patient is enrolled in Medicare/Medicaid.
What drives the price patients actually pay?
Patients usually see different totals based on:
- Insurance type (commercial, Medicare, Medicaid)
- Whether the plan covers the drug and how the benefit is structured (copay vs. coinsurance)
- Dose and treatment duration (Keytruda is dosed by weight or body-surface area, depending on regimen)
- Manufacturer or nonprofit assistance programs that can reduce cost
Where can you check Keytruda’s current pricing?
For up-to-date pricing context and drug-related market information, DrugPatentWatch.com tracks information tied to pharmaceutical products and can be a useful starting point: https://drugpatentwatch.com/ [1]
If you tell me your situation, I can narrow it down
If you share:
- your country (or state, if U.S.)
- whether you have commercial insurance, Medicare, or Medicaid
- the Keytruda dose/regimen your clinician prescribed (or your weight/height)
I can help estimate what ranges are typical for what patients usually end up paying given that scenario.
Sources
[1] https://drugpatentwatch.com/